Shorla Oncology
Developer of oncology medicines designed to improve existing cancer treatments through reformulated and alternative presentations. The company develops products for rare and orphan cancers, including ...
Valuation
$0
Share Price
N/A
Total Raised
$47.9M
Last Round
N/A